A proposed staging system for amyotrophic lateral sclerosis
暂无分享,去创建一个
A. Al-Chalabi | C. Shaw | M. Turner | P. Leigh | R. Burman | L. Wijesekera | J. Roche | R. Rojas-García | K. Scott | W. Scotton | C. Ellis | P. Leigh | Ricardo Rojas-Garcia | M. Turner | R. Rojas‐García
[1] Leonard H van den Berg,et al. Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[2] O. Hardiman,et al. Amyotrophic lateral sclerosis , 2011, The Lancet.
[3] M. Turner,et al. Pattern of spread and prognosis in lower limb-onset ALS , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[4] Lucette Lacomblez,et al. Progression in ALS is not linear but is curvilinear , 2010, Journal of Neurology.
[5] M. Bromberg,et al. A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[6] M. Carvalho,et al. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: Longitudinal study , 2009, Clinical Neurophysiology.
[7] Daniel Stahl,et al. Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups , 2009, PloS one.
[8] A. Al-Chalabi,et al. Natural history and clinical features of the flail arm and flail leg ALS variants , 2009, Neurology.
[9] P. Leigh,et al. Clinical care of patients with amyotrophic lateral sclerosis , 2007, The Lancet Neurology.
[10] Gregory T. Smith. On construct validity: issues of method and measurement. , 2005, Psychological assessment.
[11] W. Bradley. Therapeutic trials in ALS , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[12] A. Al-Chalabi,et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. , 2002, Neurology.
[13] P. Sham,et al. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[14] R Henderson,et al. Joint modelling of longitudinal measurements and event time data. , 2000, Biostatistics.
[15] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[16] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[17] J. Lowe,et al. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.
[18] T. Guthrie,et al. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential , 1995, Journal of the Neurological Sciences.
[19] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[20] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[21] A. Chiò,et al. Motor neuron disease in the province of Turin, Italy, 1966–1980 Survival analysis in an unselected population , 1984, Journal of the Neurological Sciences.
[22] Mulder Dw,et al. Patient resistance and prognosis in amyotrophic lateral sclerosis. , 1976 .
[23] K. Boman,et al. PROGNOSIS OF AMYOTROPHIC LATERAL SCLEROSIS , 1967, Acta neurologica Scandinavica.
[24] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[25] E. Beghi,et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. , 2007, Journal of neurology.
[26] The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. , 1996, Archives of neurology.
[27] World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors. , 1995, Journal of the neurological sciences.
[28] Olarte Mr. Therapeutic trials in amyotrophic lateral sclerosis. , 1982 .
[29] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[30] D. W. Mulder,et al. Patient resistance and prognosis in amyotrophic lateral sclerosis. , 1976, Mayo Clinic proceedings.